Cytomegalovirus prophylaxis in pediatric renal transplant recipients

Transplant Proc. 1993 Feb;25(1 Pt 2):1414-5.
No abstract available

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use
  • Biopsy
  • Child
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / prevention & control*
  • Ganciclovir / therapeutic use*
  • Graft Rejection / pathology
  • Graft Rejection / therapy
  • Humans
  • Immunoglobulin G / blood
  • Immunosuppression Therapy / adverse effects
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Transplantation* / immunology
  • Kidney Transplantation* / pathology
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use
  • Risk Factors

Substances

  • Antibodies, Viral
  • Antilymphocyte Serum
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Ganciclovir